Toshiba's Latest Aquilion CT Receives FDA Clearance
The Aquilion Prime CT was designed for facilities that need to perform a wide variety of advanced clinical exams and produce high-quality clinical images with reduced radiation exposure, the company said.
The latest addition to Toshiba’s Aquilion CT product line has received FDA 510(k) clearance, the company announced.
The Aquilion Prime CT was designed for healthcare facilities that need to perform a wide variety of advanced clinical exams and produce high-quality clinical images with reduced radiation exposure, according to Toshiba America Medical Systems, Inc. The system has double-slice technology and the coneXact reconstruction algorithm, and can generate 160 unique slices per rotation, enhancing MPR and 3-D-rendered images.
The Aquilion Prime features an 80-row, 0.5 mm detector, a 7.5 MHU large-capacity tube, and a 0.35-second scanning. This allows for rapid data acquisition and shorter scan times, and the faster reconstruction aims to improve throughput, the company said. The system has a 78-cm aperture gantry, and a 660-pound patient-weight capacity couch.
The system features the Adaptive Iterative Dose Reduction, the iterative process for reducing noise from the image, and NEMA XR 25 Dose Check software, aimed at increasing user awareness of dose.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
FDA Clears AI Assessment of Ischemic Core Volume on CT with Brainomix 360 Platform
April 8th 2025For patients with acute ischemic stroke, research has demonstrated that automated assessment of ischemic core volume on brain CT scans via the Brainomix 360 software is equivalent to that derived from CT perfusion.
